Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.
The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) helicase is believed to be essential for viral replication and has become an attractive target for the development of antiviral drugs. The study of helicase is useful for elucidating its involvement in positive sense single-stranded RNA vi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4154687?pdf=render |
_version_ | 1819149003000905728 |
---|---|
author | Kaneez Fatima Shilu Mathew Mohd Suhail Ashraf Ali Ghazi Damanhouri Esam Azhar Ishtiaq Qadri |
author_facet | Kaneez Fatima Shilu Mathew Mohd Suhail Ashraf Ali Ghazi Damanhouri Esam Azhar Ishtiaq Qadri |
author_sort | Kaneez Fatima |
collection | DOAJ |
description | The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) helicase is believed to be essential for viral replication and has become an attractive target for the development of antiviral drugs. The study of helicase is useful for elucidating its involvement in positive sense single-stranded RNA virus replication and to serve as templates for the design of novel antiviral drugs. In recent years, several models have been proposed on the conformational change leading to protein movement and RNA unwinding. Some compounds have been recently reported to inhibit the helicase and these include small molecules, RNA aptamers and antibodies. The current study is designed to help gain insights for the consideration of potential inhibitors for Pakistani HCV NS3 helicase protein. We have cloned, expressed and purified HCV NS3 helicase from Pakistani HCV serum samples and determined its 3D structure and employed it further in computational docking analysis to identify inhibitors against HCV genotype 3a (GT3a),including six antiviral key molecules such as quercetin, beta-carotene, resveratrol, catechins, lycopene and lutein. The conformation obtained after docking showed good hydrogen bond (HBond) interactions with best docking energy for quercetin and catechins followed by resveratrol and lutein. These anti-helicase key molecules will offer an alternative attraction to target the viral helicase, due to the current limitation with the interferon resistance treatment and presences of high rate of resistance in anti-protease inhibitor classes. |
first_indexed | 2024-12-22T13:54:41Z |
format | Article |
id | doaj.art-dd157411c1ec41e180f302ecac6622db |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-22T13:54:41Z |
publishDate | 2014-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-dd157411c1ec41e180f302ecac6622db2022-12-21T18:23:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10633910.1371/journal.pone.0106339Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.Kaneez FatimaShilu MathewMohd SuhailAshraf AliGhazi DamanhouriEsam AzharIshtiaq QadriThe nonstructural protein 3 (NS3) of hepatitis C virus (HCV) helicase is believed to be essential for viral replication and has become an attractive target for the development of antiviral drugs. The study of helicase is useful for elucidating its involvement in positive sense single-stranded RNA virus replication and to serve as templates for the design of novel antiviral drugs. In recent years, several models have been proposed on the conformational change leading to protein movement and RNA unwinding. Some compounds have been recently reported to inhibit the helicase and these include small molecules, RNA aptamers and antibodies. The current study is designed to help gain insights for the consideration of potential inhibitors for Pakistani HCV NS3 helicase protein. We have cloned, expressed and purified HCV NS3 helicase from Pakistani HCV serum samples and determined its 3D structure and employed it further in computational docking analysis to identify inhibitors against HCV genotype 3a (GT3a),including six antiviral key molecules such as quercetin, beta-carotene, resveratrol, catechins, lycopene and lutein. The conformation obtained after docking showed good hydrogen bond (HBond) interactions with best docking energy for quercetin and catechins followed by resveratrol and lutein. These anti-helicase key molecules will offer an alternative attraction to target the viral helicase, due to the current limitation with the interferon resistance treatment and presences of high rate of resistance in anti-protease inhibitor classes.http://europepmc.org/articles/PMC4154687?pdf=render |
spellingShingle | Kaneez Fatima Shilu Mathew Mohd Suhail Ashraf Ali Ghazi Damanhouri Esam Azhar Ishtiaq Qadri Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. PLoS ONE |
title | Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. |
title_full | Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. |
title_fullStr | Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. |
title_full_unstemmed | Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. |
title_short | Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. |
title_sort | docking studies of pakistani hcv ns3 helicase a possible antiviral drug target |
url | http://europepmc.org/articles/PMC4154687?pdf=render |
work_keys_str_mv | AT kaneezfatima dockingstudiesofpakistanihcvns3helicaseapossibleantiviraldrugtarget AT shilumathew dockingstudiesofpakistanihcvns3helicaseapossibleantiviraldrugtarget AT mohdsuhail dockingstudiesofpakistanihcvns3helicaseapossibleantiviraldrugtarget AT ashrafali dockingstudiesofpakistanihcvns3helicaseapossibleantiviraldrugtarget AT ghazidamanhouri dockingstudiesofpakistanihcvns3helicaseapossibleantiviraldrugtarget AT esamazhar dockingstudiesofpakistanihcvns3helicaseapossibleantiviraldrugtarget AT ishtiaqqadri dockingstudiesofpakistanihcvns3helicaseapossibleantiviraldrugtarget |